3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow MEDI 545: new trials by email Literature Review of MEDI 545 trials Research Report on MEDI 545
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus MEDI 545, Placebo - Lupus | Phase 1 | Completed | MedImmune LLC | 183 | 2007-06-01 | 2012-07-11 |
| A Multicenter Study to Evaluate the Safety and Tolerability of Single-Dose for MEDI-545 MEDI 545, Placebo - Chronic Plaque Psoriasis | Phase 1 | Completed | MedImmune LLC | 40 | 2007-02-01 | 2011-11-17 |
| Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE) MEDI-545, MEDI 545 - Lupus | Phase 1 | Completed | MedImmune LLC | 45 | 2006-03-01 | 2007-12-18 |
MedImmune LLC (3)
Canada (2) · United States (2) · Argentina (1) · Brazil (1) · Chile (1)
Barbara White, M.D. (2) · Warren Greth, M.D. (1)
PMID 19479852, PMID 21798883, PMID 23400715, PMID 23754736, PMID 33687069